CNS disorders are now being redefined through molecular signatures, circuit-level dysfunction, and digital phenotypes. This is not a technological evolution it is a structural reset of how drugs are developed, evaluated, and approved.
-
1 Beiträge
-
1 Fotos
-
0 Videos
-
Male
-
anschliessend 0 people
Search
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
